Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260510.RA6aUJRKoTpQOMQsw_NYXZK8-ooGr6EyKFI0l3SYDM_iY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260510.RA6aUJRKoTpQOMQsw_NYXZK8-ooGr6EyKFI0l3SYDM_iY130_assertion type Assertion NP1260510.RA6aUJRKoTpQOMQsw_NYXZK8-ooGr6EyKFI0l3SYDM_iY130_head.
- NP1260510.RA6aUJRKoTpQOMQsw_NYXZK8-ooGr6EyKFI0l3SYDM_iY130_assertion description "[Taken together, our results show pharmacologic inhibition of the JAK2/STAT3 pathway leads to disruption of functions essential for ovarian tumor growth and progression and represents a promising therapeutic strategy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260510.RA6aUJRKoTpQOMQsw_NYXZK8-ooGr6EyKFI0l3SYDM_iY130_provenance.
- NP1260510.RA6aUJRKoTpQOMQsw_NYXZK8-ooGr6EyKFI0l3SYDM_iY130_assertion evidence source_evidence_literature NP1260510.RA6aUJRKoTpQOMQsw_NYXZK8-ooGr6EyKFI0l3SYDM_iY130_provenance.
- NP1260510.RA6aUJRKoTpQOMQsw_NYXZK8-ooGr6EyKFI0l3SYDM_iY130_assertion SIO_000772 25646015 NP1260510.RA6aUJRKoTpQOMQsw_NYXZK8-ooGr6EyKFI0l3SYDM_iY130_provenance.
- NP1260510.RA6aUJRKoTpQOMQsw_NYXZK8-ooGr6EyKFI0l3SYDM_iY130_assertion wasDerivedFrom befree-2016 NP1260510.RA6aUJRKoTpQOMQsw_NYXZK8-ooGr6EyKFI0l3SYDM_iY130_provenance.
- NP1260510.RA6aUJRKoTpQOMQsw_NYXZK8-ooGr6EyKFI0l3SYDM_iY130_assertion wasGeneratedBy ECO_0000203 NP1260510.RA6aUJRKoTpQOMQsw_NYXZK8-ooGr6EyKFI0l3SYDM_iY130_provenance.